Peyronie's disease is a significant andrological issue characterized by the formation of inelastic hard scar tissues (plaques) in the penile sheath, making sexual intercourse difficult or impossible. Traditional treatments involving plaque injections (such as verapamil) may show limited efficacy. Exosome therapy for Peyronie's disease is an innovative approach aimed at dissolving and repairing the fibrotic structure at the cellular level, thanks to regenerative factors injected directly into the plaque. This method is safely administered to Peyronie's patients in modern urology and andrology clinics.
Therapeutic Effect of Exosomes on Plaques
MicroRNAs and growth factors within exosomes alter the structure of abnormal collagen fibers (fibrosis) accumulated in the Peyronie's plaque:
- Collagenase Activation: Stimulates the body's own enzymes (collagenase) to dissolve hardened collagen bonds within the plaque.
- Inhibition of Fibrosis: Softens the plaque by increasing the production of new and flexible collagen fibers (Type 3 collagen).
- Reduction of Curvature: As the plaque softens, the pulling effect during erection decreases, leading to a significant improvement in penile curvature and erection pain.
Exosome therapy yields highly successful results, potentially eliminating the need for surgery entirely, especially when applied during the early active phase of the disease.